# Nox1-Derived ROS Amplifies Calcium Entry and Enhances Pneumolysin-Induced Lung Endothelial Barrier Dysfunction in Hyperglycemia

**Authors:** Stephen Haigh, Feng Chen, Yanfang Yu, Zsuzsanna Bordan, Xueyi Li, Supriya Sridhar, Maritza J. Romero, Trinad Chakraborty, Gabor Csanyi, Austin T. Joshua, Tej V. Patel, Zachary L. Brown, Mitchel A. Shivers, Hunter G. Sellers, Farhana Ananna, Tohru Fukai, Masuko Ushio-Fukai, Eric J. Belin de Chantemele, Alexander Verin, David W. Stepp, Rudolf Lucas, David J. R. Fulton

PMC · DOI: 10.3390/antiox15030275 · Antioxidants · 2026-02-24

## TL;DR

High blood sugar in obese individuals worsens lung damage from a pneumonia-causing bacteria by increasing calcium entry into blood vessel cells.

## Contribution

Identifies a new signaling pathway involving NOX1, STIM1, TRPC1, and MPTP in hyperglycemia-induced lung injury.

## Key findings

- NOX1 increases superoxide and worsens endothelial barrier disruption in a dose-dependent manner.
- NOX1 inhibition reduces PLY-induced damage and calcium influx in hyperglycemic conditions.
- TRPC1 and MPTP are key mediators in the NOX1-driven pathway of endothelial dysfunction.

## Abstract

Background: Streptococcus pneumonia is the primary etiological agent of community-acquired pneumonia (CAP). Pneumococci promote severe lung injury through the release of virulence factors, including pneumolysin (PLY). Obesity/diabetes increases pneumonia-associated mortality, but the mechanisms remain elusive. We found that obese db/db mice have increased pulmonary barrier disruption to PLY. Previously we showed that upregulation of NOX1 in endothelial cells (EC) of db/db mice drives endothelial dysfunction, but a role for NOX1 in PLY-induced lung injury, especially in diabetic conditions, has not yet been described. Results: Increased NOX1 in lung ECs dose-dependently increased superoxide and EC barrier disruption (p < 0.05). Even at low activity levels, NOX1 greatly potentiated PLY-induced EC barrier disruption, whereas loss of NOX1 activity, either pharmacological or genetic, reduced barrier disruption (p < 0.05). Blockade of calcium entry protected the EC barrier from combined PLY and NOX1, indicating a key role for calcium. Hyperglycemia amplified PLY-enduced EC barrier disruption and intracellular calcium and these effects were mitigated by NOX1 inhibition and silencing (p < 0.05). NOX1-enhanced calcium entry was reduced by knockout of calcium sensor STIM1, and PLY-induced barrier disruption was reduced by STIM1 inhibition. Levels of STIM1, Orai1, TRPV4, or TRPC4 were unchanged by HG, but TRPC1 significantly increased (p < 0.05). NOX1 and HG promoted increased STIM1 and TRPC1 binding, and silencing TRPC1 ameliorated PLY-induced barrier disruption (p < 0.05). Increased calcium promoted mitochondrial permeability transition pore (MPTP) opening and PPIF inhibition protected EC barrier function (p < 0.05). Conclusions: These results suggest that elevated glucose levels in obesity primes EC barrier disruption by amplifying PLY-induced calcium influx via a novel NOX1, STIM1, TRPC1 and MPTP signaling axis.

## Linked entities

- **Genes:** NOX1 (NADPH oxidase 1) [NCBI Gene 27035], STIM1 (stromal interaction molecule 1) [NCBI Gene 6786], ORAI1 (ORAI calcium release-activated calcium modulator 1) [NCBI Gene 84876], TRPV4 (transient receptor potential cation channel subfamily V member 4) [NCBI Gene 59341], TRPC4 (transient receptor potential cation channel subfamily C member 4) [NCBI Gene 7223], TRPC1 (transient receptor potential cation channel subfamily C member 1) [NCBI Gene 7220], PPIF (peptidylprolyl isomerase F) [NCBI Gene 10105]
- **Diseases:** pneumonia (MONDO:0005249), obesity (MONDO:0011122), diabetes (MONDO:0005015)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Trpc1 (transient receptor potential cation channel, subfamily C, member 1) [NCBI Gene 22063] {aka Mtrp1, Trp1, Trrp1}, Orai1 (ORAI calcium release-activated calcium modulator 1) [NCBI Gene 109305] {aka D730049H07Rik, Tmem142a, orai-1}, Trpv4 (transient receptor potential cation channel, subfamily V, member 4) [NCBI Gene 63873] {aka 0610033B08Rik, OTRPC4, Trp12, VR-OAC, VRL-2, VROAC}, Trpc4 (transient receptor potential cation channel, subfamily C, member 4) [NCBI Gene 22066] {aka CCE1, STRPC4, Trp4, Trrp4}, Nox1 (NADPH oxidase 1) [NCBI Gene 237038] {aka GP91-2, MOX1, NOH-1, NOH1, NOX1a, NOX1alpha}, Stim1 (stromal interaction molecule 1) [NCBI Gene 20866] {aka SIM}, Ppif (peptidylprolyl isomerase F (cyclophilin F)) [NCBI Gene 105675] {aka CyP-D, CyP-F, CypD, PPIase}
- **Diseases:** Streptococcus pneumonia (MESH:D011008), endothelial dysfunction (MESH:D014652), CAP (MESH:D003147), Hyperglycemia (MESH:D006943), pneumonia (MESH:D011014), Obesity (MESH:D009765), diabetes (MESH:D003920), Lung Endothelial Barrier Dysfunction (MESH:D008171), lung injury (MESH:D055370)
- **Chemicals:** glucose (MESH:D005947), superoxide (MESH:D013481), ROS (-), Calcium (MESH:D002118)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13024285/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024285/full.md

## References

80 references — full list in the complete paper: https://tomesphere.com/paper/PMC13024285/full.md

---
Source: https://tomesphere.com/paper/PMC13024285